JP2009505964A5 - - Google Patents

Download PDF

Info

Publication number
JP2009505964A5
JP2009505964A5 JP2008524591A JP2008524591A JP2009505964A5 JP 2009505964 A5 JP2009505964 A5 JP 2009505964A5 JP 2008524591 A JP2008524591 A JP 2008524591A JP 2008524591 A JP2008524591 A JP 2008524591A JP 2009505964 A5 JP2009505964 A5 JP 2009505964A5
Authority
JP
Japan
Prior art keywords
fibrinogen binding
factor
fibrinogen
peptide
wound site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008524591A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009505964A (ja
Filing date
Publication date
Priority claimed from GBGB0516091.6A external-priority patent/GB0516091D0/en
Application filed filed Critical
Publication of JP2009505964A publication Critical patent/JP2009505964A/ja
Publication of JP2009505964A5 publication Critical patent/JP2009505964A5/ja
Pending legal-status Critical Current

Links

JP2008524591A 2005-08-04 2006-08-04 人工血小板 Pending JP2009505964A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0516091.6A GB0516091D0 (en) 2005-08-04 2005-08-04 Therapeutic agent
PCT/GB2006/002934 WO2007015107A2 (en) 2005-08-04 2006-08-04 Artificial platelets

Publications (2)

Publication Number Publication Date
JP2009505964A JP2009505964A (ja) 2009-02-12
JP2009505964A5 true JP2009505964A5 (https=) 2009-09-17

Family

ID=34984119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008524591A Pending JP2009505964A (ja) 2005-08-04 2006-08-04 人工血小板

Country Status (9)

Country Link
US (2) US20090203619A1 (https=)
EP (2) EP2335737A3 (https=)
JP (1) JP2009505964A (https=)
CN (1) CN101267843A (https=)
AU (1) AU2006274685A1 (https=)
CA (1) CA2625917A1 (https=)
GB (2) GB0516091D0 (https=)
IL (1) IL189105A0 (https=)
WO (1) WO2007015107A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
EP2120989A1 (en) * 2007-03-21 2009-11-25 DSM IP Assets B.V. Cholesterol lowering protein hydrolysates
WO2009046845A2 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of a lactoferrin partial peptide peptide as a therapeutic agent
KR20100057642A (ko) * 2007-09-11 2010-05-31 몬도바이오테크 래보래토리즈 아게 치료제로서의 cnp-22 단독 또는 피살라에민과 배합된 이의 용도
GB201101740D0 (en) 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding
WO2013021353A1 (en) * 2011-08-11 2013-02-14 Bar-Ilan University Surface modified proteinaceous spherical particles and uses thereof
GB201201751D0 (en) * 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing
WO2014197816A1 (en) * 2013-06-06 2014-12-11 Massachusetts Institute Of Technology Stimulus responsive nanocomplexes and methods of use thereof
SG10201710616XA (en) * 2013-06-28 2018-02-27 Biogen Ma Inc Thrombin cleavable linker with xten and its uses thereof
WO2015073418A2 (en) * 2013-11-15 2015-05-21 President And Fellows Of Harvard College Methods and assays for factor viii activity
GB201400292D0 (en) * 2014-01-08 2014-02-26 Haemostatix Ltd Peptide dendrimers and agents
AU2015204646B2 (en) 2014-01-10 2020-08-27 Bioverativ Therapeutics Inc. Factor VIII chimeric proteins and uses thereof
GB201508024D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions
CN107686506B (zh) * 2016-08-05 2021-03-30 首都医科大学 华法林-4-o-乙酰-gprp,其合成,活性和应用
IL319473A (en) 2016-12-02 2025-05-01 Bioverativ Therapeutics Inc Methods for treating hemophilic arthritis using chimeric blood clotting factors
CN108976285B (zh) * 2017-05-31 2021-11-30 首都医科大学 Gly-Pro-Arg-Pro-AA修饰的华法林,其合成,活性和应用
CN108976284B (zh) * 2017-05-31 2021-11-30 首都医科大学 含Gly-Pro-Arg-Pro的五肽修饰的华法林,其合成,活性和应用
JP7320599B2 (ja) * 2018-04-24 2023-08-03 フィブリアント・ベスローテン・フェンノートシャップ フィブリノーゲンガンマプライム変種の治療的使用
BR112020022164A2 (pt) 2018-05-18 2021-02-02 Bioverativ Therapeutics Inc. métodos de tratamento de hemofilia a
CN115010784B (zh) * 2022-05-16 2023-03-31 江南大学 一种ace抑制肽及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
ATE329624T1 (de) * 1992-05-21 2006-07-15 Diatide Inc Technetium-99m markierte peptide zur bilderzeugung von thrombus
US6184205B1 (en) * 1994-07-22 2001-02-06 University Of North Carolina At Chapel Hill GRB2 SH3 binding peptides and methods of isolating and using same
DE69526665T2 (de) * 1994-09-21 2002-11-21 Cytogen Corp., Princeton Antigen bindende peptide (abtides) aus peptidbibliotheken
ES2232862T3 (es) * 1996-10-21 2005-06-01 Quadrant Drug Delivery Limited Sustitutos de plaquetas y procedimientos de conjugacion apropiados para su preparacion.
WO1998055105A1 (en) * 1997-06-05 1998-12-10 Hemosphere, Inc. Fibrinogen-coated microspheres
DK9700423U3 (da) * 1997-11-10 1999-03-12 Simatek A S Multifunktion cip-dyse
WO1999042146A1 (en) * 1998-02-20 1999-08-26 Quadrant Healthcare (Uk) Limited Products comprising fibrinogen for use in therapy
GB9827813D0 (en) * 1998-12-17 1999-02-10 Andaris Ltd Pharmaceutical conjugates
US6984373B2 (en) * 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
GB0413346D0 (en) * 2004-06-15 2004-07-21 Theryte Ltd Treating cancer
GB201201751D0 (en) * 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing

Similar Documents

Publication Publication Date Title
JP2009505964A5 (https=)
US9493513B2 (en) Polypeptides and their use
CN102590490B (zh) 测定凝固抑制剂的方法
JP2010180217A5 (https=)
JP2001511347A5 (https=)
CA2316280A1 (en) Novel g protein-coupled receptor
JP2003534013A5 (https=)
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
JP2002543825A5 (https=)
JP2013505287A5 (https=)
WO2005087811A3 (en) Estrogen receptors and methods of use
JP2004512010A5 (https=)
WO2008105178A1 (ja) リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム
JP2008519592A5 (https=)
JP2006503088A5 (https=)
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
CN110669109A (zh) 一种酶联标签短肽及其应用
JP2001517445A5 (https=)
WO2007064844A3 (en) Anti-viral griffithsin compounds, compositions, and methods of use
JP2009525741A5 (ja) HERV−W干渉群に属するウィルスの包膜とhASCT受容体との間の相互作用に必要なペプチド領域からなるペプチド
JP2005509160A5 (https=)
Käkönen et al. Purification and characterization of recombinant osteocalcin fusion protein expressed inEscherichia coli
CA2597545A1 (en) Antibody for assay of adamts13 activity and method for assaying the activity
DE502005004379D1 (de) Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung
JP2005528894A5 (https=)